The third VERDI General Assembly meeting took place on 26-27 June 2023, in Ayia Napa, Cyprus, with over 70 participants from 29 centres of excellence within the VERDI Consortium attending the event, both online and in person. This meeting was particularly noteworthy...
Your Title Goes Here
VERDI’s Maternal-Infant Working Group: Prioritising pregnant women and their babies in COVID-19 research
Did you know that within VERDI there are 4 Working Groups? These groups help our VERDI partners actively exchange ideas, designs, methods and results, while also identifying gaps and collaborative opportunities. Today, we are happy to present you the VERDI...
VERDI’s Clinical Working Group: Understanding COVID-19’s effects on children
Did you know that within VERDI there are 4 Working Groups? These groups help our VERDI partners actively exchange ideas, designs, methods and results, while also identifying gaps and collaborative opportunities. Today, we are excited to present you the VERDI...
Register for the END-VOC scientific symposium “COVID-19 variants and the next pandemic”
The EU-funded END-VOC project is organising the online scientific symposium "COVID-19 variants and the next pandemic", which will be held on 6 June 2023, 14.00–18.00 CEST. The symposium will focus on lessons learned from COVID-19 and how to anticipate the next...
“It is rewarding to witness VERDI activity informing the policy response”
Ali Judd, VERDI co-scientific coordinator, shares insights on her experience with the VERDI Consortium. This story is taken from Penta’s 2022 Social Report. “Despite having a very short window in which to write the VERDI proposal, it was amazing that so many...
EU tasks VERDI Consortium with investigating mpox and improving pandemic preparedness
The VERDI Consortium, coordinated by the University of Padua and Fondazione Penta ETS (Italy), has received an additional €5 million funding from the European Union (EU). Thanks to this contribution, VERDI will examine the impact of mpox on populations at higher risk...
Join VERDI’s clinical study in paediatric and adolescent mpox
We would like to invite hospitals to participate in a study of mpox in children and adolescents globally. This mpox paediatric and adolescent clinical study is a Joint EU Clinical Research Initiative which is part of the VERDI project, in collaboration with...
VERDI General Assembly highlights importance of synergies across cohorts and consortia
The second VERDI General Assembly took place from 28-30 June 2022, bringing together more than 70 people both online and in Padua, Italy. This hybrid meeting spotlighted the important work carried out by different working groups and allowed members to share updates on...
Study reveals moderate effectiveness of Pfizer Covid-19 vaccine against Omicron in children aged 5-11
PRESS RELEASE A large study on the effectiveness of the Pfizer Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine. The study was conducted at Israel’s largest healthcare organization, Clalit Health Services, in collaboration...
VERDI General Assembly Meeting
On 26-28 January the VERDI General Assembly Meeting took place – an exciting 3-day online event bringing together experts in infectious diseases from the EU and beyond. The aim was to share our workplan, identify research areas of interest for the Consortium and...